HUTCHMED (China) (HCM) Non-Current Assets (2015 - 2026)
HUTCHMED (China) (HCM) posted quarterly Non-Current Assets of $183.0 million for Q2 2026, up 178.87% year-over-year from $65.6 million in Q2 2025, and up 176.83% quarter-over-quarter from $66.1 million in Q4 2025.
HUTCHMED (China) (HCM) Non-Current Assets (2015 - 2026) Analysis & Trends
HUTCHMED (China) (HCM) has reported Non-Current Assets for 12 consecutive years, with $183.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets rose 178.87% year-over-year to $183.0 million; the TTM figure through Jun 2026 stood at $763.9 million (up 1064.01% YoY), while the FY2025 annual figure was $66.1 million, down 2.15% from the prior year.
- Non-Current Assets rose to $183.0 million in Q2 2026 per HCM's latest filing, from $66.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $207.0 million in Q2 2023 and bottomed at $65.6 million in Q2 2025.
- Historically, Non-Current Assets has averaged $99.7 million across 5 years, with a median of $73.9 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Assets slumped 66.52% — and 2026, when it jumped 178.87%.
- HUTCHMED (China)'s Non-Current Assets stood at $80.1 million in 2022, then declined by 7.65% to $73.9 million in 2023, then slipped by 8.63% to $67.6 million in 2024, then dropped by 2.15% to $66.1 million in 2025, then surged by 176.83% to $183.0 million in 2026.
- Business Quant data shows HCM's Non-Current Assets at $183.0 million in Q2 2026, $66.1 million in Q4 2025, and $65.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | 183.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 183.02 Mn |
| Dec 31, 2025 | 66.11 Mn |
| Jun 30, 2025 | 65.63 Mn |
| Dec 31, 2024 | 67.56 Mn |
| Jun 30, 2024 | 69.31 Mn |
| Dec 31, 2023 | 73.94 Mn |
| Jun 30, 2023 | 207.01 Mn |
| Dec 31, 2022 | 80.06 Mn |
| Jun 30, 2022 | 84.97 Mn |
| Dec 31, 2021 | 91.61 Mn |
| Jun 30, 2021 | 93.36 Mn |
| Mar 31, 2021 | 196.89 Mn |
| Dec 31, 2020 | 95.73 Mn |
| Jun 30, 2020 | 91.43 Mn |
| Dec 31, 2019 | 95.10 Mn |
| Sep 30, 2019 | 177.01 Mn |
| Jun 30, 2019 | 185.72 Mn |
| Mar 31, 2019 | 189.30 Mn |
| Dec 31, 2018 | 161.58 Mn |
| Jun 30, 2018 | 183.27 Mn |